-
Cyclin-dependent kinase 4/6 inhibitors combined with radiation therapy for patients with metastatic breast cancerRatoša, Ivica ...The cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) represent the standard treatment for hormone receptor positive, human epidermal growth factor receptor 2 negative metastatic breast cancer ... (MBC). Data regarding toxicity safety profiles when combining CDK4/6i with palliative radiotherapy (RT) are lacking. Material and methods We undertook a review of 46 MBC patients on systemic treatment with CDK4/6i who underwent 62 metastases-directed RT. Clinical, laboratory, and RT treatment planning data were collected. Statistical analyses included a Student%s t-test, a paired sample t-test, and a logistic regression model. Results Thirty patients (65.2%) received palbociclib, 15 (32.6%) received ribociclib, and one patient received abemaciclib (2.2%). Median total (TD) prescribed RT dose was 20 Gy (range: 8%63 Gy). Sites of RT were bone (n=50; 80.7%), visceral (n=7; 11.3%), or brain metastases (n=3; 4.8%), as well as primary tumor of the breast (n=2; 3.2%). Overall, the rates of %G3 adverse events (AEs) were 6.5%, 4.3%, 15.2%, and 23.9% before the start of RT, during RT, two and six weeks after RT completion, respectively. A logistic regression analysis accounting for age, type of CDK4/6i, CDK4/6i suspension during RT, planning target volume, TD, and RT technique found that none of these factors had a negative effect on the cumulative toxicity of any grade. We found no correlation between dose distribution to at-risk organs and the development of AEs. Conclusions We observed a modest increase in the rates of %G3 AEs following RT. Nevertheless, serious AE incidence was similar to previous pivotal CDK4/6i trials.Source: Clinical breast cancer. - ISSN 1526-8209 (Vol. 20, iss. 6, 2020, str. 495-502)Type of material - article, component partPublish date - 2020Language - englishCOBISS.SI-ID - 20094723
Author
Ratoša, Ivica |
Oražem, Miha, zdravnik, 1989- |
Scoccimarro, Erika |
Steinacher, Mateja |
Dominici, Luca |
Aquilano, Michele |
Cerbai, Cecilia |
Desideri, Isacco |
Ribnikar, Domen |
Marinko, Tanja, medicina
Topics
metastatski rak dojke |
radioterapija |
zaviralci od ciklina odvisnih kinaz |
neželeni učinki |
metastatic breast cancer |
radiation therapy |
cyclin-dependent kinase inhibitors |
adverse events
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Ratoša, Ivica | 34883 |
Oražem, Miha, zdravnik, 1989- | 39125 |
Scoccimarro, Erika | |
Steinacher, Mateja | |
Dominici, Luca | |
Aquilano, Michele | |
Cerbai, Cecilia | |
Desideri, Isacco | |
Ribnikar, Domen | 36202 |
Marinko, Tanja, medicina | 34225 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.